List of SBIR/STTR awards granted to Ambergen

where

SBIR/STTR Award Recipient

Ambergen

Name	Description	SBIR/STTR Award Recipient	Government Branch	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
‌ AMBERGEN, INC SBIR Phase II Award, August 2020	A SBIR Phase II contract was awarded to Ambergen in August, 2020 for $1,249,958.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Ambergen	National Institutes of Health	SBIR	1R44AG067866-01	Phase II	1,249,958	August 1, 2020	sbir.gov/node/1911813
‌ AMBERGEN, INC SBIR Phase II Award, September 2019	A SBIR Phase II contract was awarded to Ambergen in September, 2019 for $999,744.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Ambergen	National Institutes of Health	SBIR	2R44CA236097-02	Phase II	999,744	September 18, 2019	sbir.gov/node/1687211
‌ AMBERGEN, INC SBIR Phase I Award, September 2018	A SBIR Phase I contract was awarded to Ambergen in September, 2018 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Ambergen	National Institutes of Health	SBIR	1R43CA236097-01	Phase I	300,000	September 1, 2018	sbir.gov/node/1571979
‌ AMBERGEN, INC SBIR Phase II Award, January 2018	A SBIR Phase II contract was awarded to Ambergen in January, 2018 for $1,937,987.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Ambergen	National Institutes of Health	SBIR	2R44AI100424-06	Phase II	1,937,987	January 9, 2018	sbir.gov/node/1565283
‌ AMBERGEN, INC SBIR Phase II Award, September 2022	A SBIR Phase II contract was awarded to Ambergen in September, 2022 for $1,084,108.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Ambergen	National Institutes of Health	SBIR	1R44MH132196-01	Phase II	1,084,108	September 15, 2022	sbir.gov/node/2341673
‌ AMBERGEN, INC SBIR Phase II Award, August 2022	A SBIR Phase II contract was awarded to Ambergen in August, 2022 for $978,625.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Ambergen	National Institutes of Health	SBIR	1R44AI165129-01A1	Phase II	978,625	August 19, 2022	sbir.gov/node/2338623
‌ AMBERGEN, INC SBIR Phase II Award, September 2022	A SBIR Phase II contract was awarded to Ambergen in September, 2022 for $1,354,952.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Ambergen	National Institutes of Health	SBIR	1R44AG078097-01	Phase II	1,354,952	September 1, 2022	sbir.gov/node/2338797
‌ AMBERGEN, INC SBIR Phase II Award, March 2014	A SBIR Phase II contract was awarded to Ambergen in March, 2014 for $2,996,715.0 USD from the U.S. Department of Health & Human Services.	Ambergen		SBIR	2R44AI100424-03	Phase II	2,996,715	March 1, 2014	sbir.gov/node/1031203
‌ AMBERGEN, INC SBIR Phase II Award, August 2014	A SBIR Phase II contract was awarded to Ambergen in August, 2014 for $999,489.0 USD from the U.S. Department of Health & Human Services.	Ambergen		SBIR	2R44CA161965-03	Phase II	999,489	August 1, 2014	sbir.gov/node/1046047
‌ AMBERGEN, INC SBIR Phase II Award, September 2016	A SBIR Phase II contract was awarded to Ambergen in September, 2016 for $2,260,500.0 USD from the U.S. Department of Health & Human Services.	Ambergen		SBIR	2R44GM105249-03	Phase II	2,260,500	September 1, 2016	sbir.gov/node/1199245
‌ AMBERGEN, INC SBIR Phase I Award, August 2016	A SBIR Phase I contract was awarded to Ambergen in August, 2016 for $225,000.0 USD from the U.S. Department of Health & Human Services.	Ambergen		SBIR	1R43CA203647-01A1	Phase I	225,000	August 1, 2016	sbir.gov/node/1197029
‌ AMBERGEN, INC SBIR Phase I Award,	A SBIR Phase I contract was awarded to Ambergen for $99,992.0 USD from the U.S. Department of Health & Human Services.	Ambergen		SBIR	1R43GM070325-01	Phase I	99,992		sbir.gov/content/photocleavable-icat-reagents-quantitative-proteomics-0
‌ AMBERGEN, INC SBIR Phase II Award,	A SBIR Phase II contract was awarded to Ambergen for $749,000.0 USD from the U.S. Department of Health & Human Services.	Ambergen		SBIR	2R44GM070325-02	Phase II	749,000		sbir.gov/content/photocleavable-icat-reagents-quantitative-proteomics-2
‌ AMBERGEN, INC SBIR Phase II Award,	A SBIR Phase II contract was awarded to Ambergen for $848,857.0 USD from the U.S. Department of Health & Human Services.	Ambergen		SBIR	2R44AI058620-03A1	Phase II	848,857		sbir.gov/content/mass-spectrometric-detection-drug-resistant-hiv-0
‌ AMBERGEN, INC SBIR Phase I Award,	A SBIR Phase I contract was awarded to Ambergen for $150,000.0 USD from the U.S. Department of Health & Human Services.	Ambergen		SBIR	1R43NS053110-01	Phase I	150,000		sbir.gov/content/advanced-molecular-diagnostic-test-neurofibromatosis-0
‌ AMBERGEN, INC SBIR Phase I Award,	A SBIR Phase I contract was awarded to Ambergen for $188,151.0 USD from the U.S. Department of Health & Human Services.	Ambergen		SBIR	1R43CA137948-01A1	Phase I	188,151		sbir.gov/node/1613
‌ AMBERGEN, INC SBIR Phase I Award,	A SBIR Phase I contract was awarded to Ambergen for $596,918.0 USD from the U.S. Department of Health & Human Services.	Ambergen		SBIR	1R43AI100424-01	Phase I	596,918		sbir.gov/node/399768
‌ AMBERGEN, INC SBIR Phase II Award,	A SBIR Phase II contract was awarded to Ambergen for $1,259,950.0 USD from the U.S. Department of Health & Human Services.	Ambergen		SBIR	2R44CA114126-02	Phase II	1,259,950		sbir.gov/content/advanced-technology-assaying-cancer-drug-resistance-2
‌ AMBERGEN, INC SBIR Phase I Award,	A SBIR Phase I contract was awarded to Ambergen for $199,767.0 USD from the U.S. Department of Health & Human Services.	Ambergen		SBIR	N43CO120071	Phase I	199,767		sbir.gov/node/402291
‌ AMBERGEN, INC SBIR Phase I Award,	A SBIR Phase I contract was awarded to Ambergen for $99,969.0 USD from the U.S. Department of Health & Human Services.	Ambergen		SBIR	1R43GM067318-01	Phase I	99,969		sbir.gov/content/cell-free-protein-labeling-molecular-partners-0
‌ AMBERGEN, INC SBIR Phase II Award,	A SBIR Phase II contract was awarded to Ambergen for $1,463,364.0 USD from the U.S. Department of Health & Human Services.	Ambergen		SBIR	2R44CA137948-02A1	Phase II	1,463,364		sbir.gov/node/389031
‌ AMBERGEN, INC SBIR Phase I Award,	A SBIR Phase I contract was awarded to Ambergen for $154,247.0 USD from the U.S. Department of Health & Human Services.	Ambergen		SBIR	1R43CA119565-01	Phase I	154,247		sbir.gov/content/novel-invasive-crc-test-based-mass-spec-vitro-expressed-proteins-0
‌ AMBERGEN, INC SBIR Phase I Award,	A SBIR Phase I contract was awarded to Ambergen for $299,730.0 USD from the U.S. Department of Health & Human Services.	Ambergen		SBIR	1R43CA161965-01	Phase I	299,730		sbir.gov/content/global-proteomic-screening-maldi-spectrometric-imaging-protein-bead-arrays
‌ AMBERGEN, INC SBIR Phase II Award,	A SBIR Phase II contract was awarded to Ambergen for $1,573,640.0 USD from the U.S. Department of Health & Human Services.	Ambergen		SBIR	2R44CA121473-02A2	Phase II	1,573,640		sbir.gov/content/novel-methods-molecular-analysis-colorectal-cancer-tissue-0
‌ AMBERGEN, INC SBIR Phase II Award,	A SBIR Phase II contract was awarded to Ambergen for $381,938.0 USD from the U.S. Department of Health & Human Services.	Ambergen		SBIR	2R44CA119565-02	Phase II	381,938		sbir.gov/content/novel-non-invasive-crc-test-based-mass-spec-vitro-expressed-proteins-0

Results per page:

51 results

0 selected

51 results

0 selected